LeadIQ logo
Learn more at LeadIQ.com

MoonLake Immunotherapeutics (NASDAQ: MLTX) Employee Directory

Biotechnology ResearchZug, Switzerland51-200 Employees

MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

Find MoonLake Immunotherapeutics (NASDAQ: MLTX) employees' phone numbers or email addresses

MoonLake Immunotherapeutics (NASDAQ: MLTX) Global Highlights

Location
Employees

Europe
134

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    54
  • Portugal
    40
  • Switzerland
    33
  • Belgium
    2
  • Germany
    2
  • France
    1
  • Ireland
    1
  • Italy
    1

North America
2

Minus sign iconPlus sign icon
  • United States Of America
    2

South America
1

Minus sign iconPlus sign icon
  • Brazil
    1

MoonLake Immunotherapeutics (NASDAQ: MLTX)'s Leadership

  • Stylized image of a person
    M. B.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    O. D.
    Chief Technical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    W. O. B.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    N. B.
    Chief Clinical Development Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. A.
    Vp Marketing, Market Access & Pricing
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. F. M.
    Vice President Clinical Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. S. D. S.
    Founder & Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. R.
    Co-Founder And Chief Scientific Officer
    Phone icon
    Mobile Phone

MoonLake Immunotherapeutics (NASDAQ: MLTX) Employee Metrics

100%
50%
0%
2026
2025
  • Administrative
  • Business
  • Legal
  • Human Resources
  • Program & Project Management
  • Other
  • Biotechnology

Contact profiles from MoonLake Immunotherapeutics (NASDAQ: MLTX)

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    J. F. M.
    Vice President Clinical Development
    Phone icon
    Mobile Phone
    PortugalPorto District
    Feb 11, 2026
  • Stylized image of a person
    L. M. M.
    Associate Vice President
    Phone icon
    Mobile Phone
    PortugalAveiro
    Nov 24, 2025
  • Stylized image of a person
    F. G.
    Vice President
    Phone icon
    Mobile Phone
    United KingdomEngland
    Feb 05, 2026
  • Stylized image of a person
    A. P.
    Senior Director Clinical Operations
    Phone icon
    Mobile Phone
    PortugalPorto District
    Feb 11, 2026
  • Stylized image of a person
    T. T.
    Associate Director, Corporate Development
    Phone icon
    Mobile Phone
    SwitzerlandZurich
    Feb 04, 2026
  • Stylized image of a person
    T. O.
    Senior Medical Director
    Phone icon
    Mobile Phone
    United Kingdom
    Feb 11, 2026
  • Stylized image of a person
    N. A.
    Senior Director Global Medical Affairs
    Phone icon
    Mobile Phone
    United KingdomEngland
    Feb 11, 2026
  • Stylized image of a person
    A. J.
    Senior Director Clinical Operations
    Phone icon
    Mobile Phone
    United Kingdom
    Feb 10, 2026
  • Stylized image of a person
    L. W.
    Associate Director Clinical Operations
    Phone icon
    Mobile Phone
    United Kingdom
    Feb 10, 2026
  • Stylized image of a person
    A. M.
    Senior Director, Global Marketing - Dermatology & Rheumatology
    Phone icon
    Mobile Phone
    Ireland
    Feb 11, 2026

Frequently Asked Questions

What is MoonLake Immunotherapeutics (NASDAQ: MLTX) known for?

Minus sign iconPlus sign iconMoonLake Immunotherapeutics (NASDAQ: MLTX) was founded in 2021 operates in the Biotechnology Research industry. The company's main headquarters is located in 29 Dorfstrasse Zug, Zug 6300 Switzerland. Explore MoonLake Immunotherapeutics (NASDAQ: MLTX)'s company overview page for more information.

What is MoonLake Immunotherapeutics (NASDAQ: MLTX)'s most common email format?

Minus sign iconPlus sign iconMoonLake Immunotherapeutics (NASDAQ: MLTX) employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more MoonLake Immunotherapeutics (NASDAQ: MLTX) email formats with LeadIQ.

How many employees does MoonLake Immunotherapeutics (NASDAQ: MLTX) have currently?

Minus sign iconPlus sign iconMoonLake Immunotherapeutics (NASDAQ: MLTX) has approximately 136 employees as of February 2026. These team members are located across 3 continents, including EuropeNorth AmericaSouth America.

Who are MoonLake Immunotherapeutics (NASDAQ: MLTX)'s key employees and leadership?

Minus sign iconPlus sign icon

As of February 2026, MoonLake Immunotherapeutics (NASDAQ: MLTX)'s key employees include:

  • Chief Financial Officer: M. B.
  • Chief Technical Officer: O. D.
  • Chief Medical Officer: W. O. B.
  • Chief Clinical Development Officer: N. B.
  • Vp Marketing, Market Access & Pricing: T. A.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

  • B2B data verified in real-time
  • Sync data to your CRM, & add it to an outreach sequence in one click
  • Integrations with your tech stack for optimal efficiency
  • A patented AI cold email generator
  • Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.